Table: begin end state 1 28 non-cytoplasmic 29 49 transmembrane 50 60 cytoplasmic 61 80 transmembrane 81 99 non-cytoplasmic 100 125 transmembrane 126 161 cytoplasmic 162 181 transmembrane 182 186 non-cytoplasmic 187 206 transmembrane 207 265 cytoplasmic 266 287 transmembrane 288 301 non-cytoplasmic 302 328 transmembrane 329 339 cytoplasmic 340 358 transmembrane 359 363 non-cytoplasmic 364 385 transmembrane 386 392 cytoplasmic 393 420 transmembrane 421 425 non-cytoplasmic 426 447 transmembrane 448 458 cytoplasmic
Input: >BPHYT_RS22690 FitnessBrowser__BFirm:BPHYT_RS22690 MQQPIQSSSADAATPQGVTASTARRSKARYQILALLAVGTMINYLDRTVLGIAAPQLTKE LGINAALMGLLFSVFSWSYVASQIPGGLFLDRFGSKLTYFLSMTLWSLCTLAQGLVHGIG ALFAFRLGLGVSEAPCFPTNSRVVATWFPQSERAMATGTYTVGEYIGLAFFSPFLFMLMG AFGWRSLFYVVGGVGIVFGGIWWMFYREPRDHPSANQAELDYIEAGGGLTHRKKDADSAG GADAASAKSGGFEWRTIGRLLKHRQLTGICLGQFAGNSTLVFFLTWFPTYLATERHMAWL KIGFFAIMPFIAASIGVMFGGFFSDWLLRRGKSPNVARKLPIIAGLLLASTIILANYVES NVAVIAILSVAFFAQGMAALGWTLVSDIAPDGLLGVTGGIFNFAANLAGIVTPLVVGFIV AATGSFVGALVFIGAIALIGALSYIFIVGDIKRIVLVD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server